Creation of an Ecological Tool Assessing Episodic Memory in Geriatrics (ECOTESTGER)

May 5, 2026 updated by: Centre Hospitalier de Lens

Creation of an Ecological Tool Assessing Episodic Memory in Geriatrics: an Adaptation of the Memory Test With Self-Initiated Items (MAI)

In this study the participants can be recruited via scheduled consultation and external institutions (associations, senior club..). Neuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease.

Study test is ecological MAI. This test are assigned in two groups (with or without neurocognitive disorders).

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

In this study the participants can be recruited via scheduled consultation and external institutions (associations, senior club..). Neuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease.

Study test is ecological MAI. Participation will be 30 minutes for patients see in case of routine care and 2h30 for those accompanying the patients and participants recruited in external institutions.

Participants are assigned in two groups. Group 1 : with neurocognitive disorders Group 2 : without neurocognitive disorders

Benefits :

For participants without neurodegenerative disorder, study enables to take control early if anomaly will be detected.

The study permit to have cognitive assessment.

Risk : It's possible that participants feel tired. No constraints for participants seen during scheduled consultation.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • France
      • Lens, France, 62408
        • Recruiting
        • Centre Hospiralier de Lens
        • Contact:
        • Principal Investigator:
          • BRUNHILDE CANESSON

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Male or female ≥ 70 ans
  • Person have good locomotion, move independently
  • Personne agree to participate

Groupe 1 : 17≤MMSE≤24 (GRECO) Diagnosis of neurodegenerative diseases (major neurocognitive disorders: Alzheimer, mixed dementia, lobar frontotemporal degeneration, vascular dementia).

Groupe 2 : MMSE ≥ à 25 (GRECO) Without neurodegenerative disease

Exclusion Criteria:

  • Person with legal protective measures
  • Person deprived of liberty
  • Mental retardation or MMSE≤ 16
  • Understanding verbal disorders
  • Visual major disturbances
  • Person with disease causing increased fatigue
  • Person with psychiatric pathology excepted anxiety disorder or depression with mild episodes.
  • Person not covered by French national health insurance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Groupe 1 : with neurocognitive disorders
with neurocognitive disorders
Diagnostic test: ecological MAI test

Neuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease.

Study test is ecological MAI.
Other: Groupe 2 : without neurocognitive disorders
without neurocognitive disorders
Diagnostic test: ecological MAI test

Neuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease.

Study test is ecological MAI.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To compare performance obtaining to overall score remind ecological MAI between older persons with neurocognitive disorders (groupe 1) and older persons without neurocognitive disorders (groupe 2).
Time Frame: day 1
Overall score remind ecological MAI test (0 to 12) in two groups.
day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To compare between case and control the various dimensions of episodic memory: temporal component, space component and association component.
Time Frame: day 1
Spatial component is defined by localisation score. Score (0 to 12)
day 1
To compare between case and control the various dimensions of episodic memory: temporal component, space component and association component.
Time Frame: day 1

Temporal component is defined by temporal dimension.

Score (0 to 12)
day 1
To compare between case and control the various dimensions of episodic memory: temporal component, space component and association component.
Time Frame: day 1

Association component is defined by binding score.

Score (0 to 12)
day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Hospitalier de Lens

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 8, 2023

Primary Completion (Estimated)

March 8, 2028

Study Completion (Estimated)

March 9, 2028

Study Registration Dates

First Submitted

December 9, 2022

First Submitted That Met QC Criteria

December 19, 2022

First Posted (Actual)

December 30, 2022

Study Record Updates

Last Update Posted (Actual)

May 8, 2026

Last Update Submitted That Met QC Criteria

May 5, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2022-02
  • 2022-A02139-34 (Other Identifier: ID-RCB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe